News

Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
Futurism on MSN3h
Human Experiments on GLP-1 Pill Looking Extremely Promising
A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.
CNN on MSN11d
More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness
The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and ...
Medical Marketing & Media2d
Eli Lilly’s GLP-1 pill aces late-stage trial days after Pfizer pulls theirs
The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its ...
WBUR2d
Why Blue Cross Blue Shield is rolling back coverage of GLP-1 weight loss drugs in Massachusetts
Massachusetts' largest commercial health insurer is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for ...
HR Executive9d
The future of GLP-1 drugs for obesity treatment: cost, access and more
Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...
Medscape10d
The Era of Compounded GLP-1 Drugs Is Over. What Now?
Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.
TCTMD3d
Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says
Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...